<Disease><Name>HYPERPIPECOLATEMIA</Name><Synonym /><OMIM><Number>239400</Number><URL>http://omim.org/entry/239400</URL></OMIM><Orphanet><Number>34</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=34</URL></Orphanet><Protein><Number /><URL /></Protein><ExPASy><Number /><URL /></ExPASy><Gene>unknown</Gene><ICD /><Summary>rare ;autosomal recessive ;allelic with Zellweger syndrome ? There is evidence, that this is a symptom of Zellweger Syndrome and not a defined disease. It is also observed in familial hyperlysinemia.;-&gt; Removed from OMIM database</Summary><Symptoms><symtomp><id>2074</id><symptom>Amino acids, plasma</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>2227</id><symptom>dysmorphism / dysmorphic features</symptom><category>HEAD</category></symtomp><symtomp><id>2423</id><symptom>early death</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2433</id><symptom>hearing defect, deafness</symptom><category>EARS | NERVOUS SYSTEM</category></symtomp><symtomp><id>1994</id><symptom>hepatomegaly (large liver)</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>1897</id><symptom>hypotonia</symptom><category>MUSCLES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2424</id><symptom>mental retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1917</id><symptom>neurological deterioration / neurologic deterioration</symptom><category>GENERAL TOPICS | NERVOUS SYSTEM</category></symtomp><symtomp><id>1723</id><symptom>nystagmus</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2504</id><symptom>onset, neonatal / neonatal</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1739</id><symptom>optic atrophy</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>1731</id><symptom>retinitis pigmentosa</symptom><category>EYES</category></symtomp><symtomp><id>1943</id><symptom>seizures</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp></Symptoms><Metabolites><metabolite><id>1650</id><name>L-Lysine</name><specimen>urine</specimen><value /><min>3.70</min><max>51.30</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1954</id><name>L-Lysine</name><specimen>plasma</specimen><value>increased</value><min>0.00</min><max>239.00</max><unit>&#956;mol/l</unit><age>Adulthood</age><method>HPLC</method><comment /></metabolite><metabolite><id>1955</id><name>L-Lysine</name><specimen>plasma</specimen><value>increased</value><min>116.00</min><max>276.00</max><unit>&#956;mol/l</unit><age>Adolescence</age><method>HPLC</method><comment /></metabolite><metabolite><id>1916</id><name>L-Lysine</name><specimen>urine</specimen><value>increased</value><min>10.00</min><max>56.00</max><unit>mmol/mol creatinine</unit><age>Adolescence</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>1917</id><name>L-Lysine</name><specimen>urine</specimen><value>increased</value><min>7.00</min><max>58.00</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>2029</id><name>L-Lysine</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>Bruker 2018</comment></metabolite><metabolite><id>26</id><name>L-Lysine</name><specimen>urine</specimen><value>increased</value><min>10.00</min><max>69.00</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>471</id><name>L-Lysine</name><specimen>urine</specimen><value>increased</value><min>22.00</min><max>171.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>876</id><name>L-Lysine</name><specimen>urine</specimen><value>increased</value><min>13.00</min><max>199.00</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>25</id><name>L-Lysine</name><specimen>plasma</specimen><value>increased</value><min>92.00</min><max>325.00</max><unit>&#956;mol/l</unit><age>Neonatal</age><method>HPLC</method><comment /></metabolite><metabolite><id>41</id><name>L-Lysine</name><specimen>plasma</specimen><value>increased</value><min>52.00</min><max>196.00</max><unit>&#956;mol/l</unit><age>Infancy</age><method>HPLC</method><comment /></metabolite><metabolite><id>42</id><name>L-Lysine</name><specimen>plasma</specimen><value>increased</value><min>66.00</min><max>270.00</max><unit>&#956;mol/l</unit><age>Childhood</age><method>HPLC</method><comment /></metabolite><metabolite><id>335</id><name>L-Lysine</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>10.00</min><max>25.00</max><unit>&#956;mol/l</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>433</id><name>Pipecolic acid</name><specimen>urine</specimen><value>increased</value><min>0.50</min><max>35.00</max><unit>mmol/mol creatinine</unit><age>infancy</age><method>GCMS</method><comment /></metabolite><metabolite><id>435</id><name>Pipecolic acid</name><specimen>urine</specimen><value>increased</value><min>0.10</min><max>3.50</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method>GCMS</method><comment /></metabolite><metabolite><id>2036</id><name>Pipecolic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>Bruker 2018</comment></metabolite><metabolite><id>428</id><name>Pipecolic acid</name><specimen>plasma</specimen><value>increased</value><min>0.80</min><max>5.30</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>429</id><name>Pipecolic acid</name><specimen>plasma</specimen><value>increased</value><min>0.50</min><max>3.80</max><unit>&#181;mol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>430</id><name>Pipecolic acid</name><specimen>plasma</specimen><value>increased</value><min>0.40</min><max>4.90</max><unit>&#181;mol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>431</id><name>Pipecolic acid</name><specimen>plasma</specimen><value>increased</value><min>0.70</min><max>2.60</max><unit>&#181;mol/l</unit><age>&gt;5 years</age><method /><comment /></metabolite><metabolite><id>432</id><name>Pipecolic acid</name><specimen>urine</specimen><value>increased</value><min>13.90</min><max>44.70</max><unit>&#181;mol/g creatinine</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>434</id><name>Pipecolic acid</name><specimen>urine</specimen><value>increased</value><min>1.60</min><max>13.40</max><unit>&#181;mol/g creatinine</unit><age>child</age><method /><comment /></metabolite><metabolite><id>851</id><name>Pipecolic oxidase</name><specimen>Liver</specimen><value>decreased</value><min>    </min><max>100.00</max><unit>% activity</unit><age>no data</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>2421</id><title>Hyperpipecolic acidemia: clinical, biochemical, and radiologic observations</title><author>Al-Essa MA</author><journal>Pediatr Neurol</journal><year>1999</year><book /><volume>21</volume><number>5</number><pages>826-829</pages><co_aut>et al.</co_aut></literature><literature><id>72</id><title>Errors of lysine metabolism</title><author>Cox RP</author><journal>The metabolic and molecular bases of inherited disease, 7/e; Editors: C.R.Scriver, A.L.Beaudet, W.S.Sly, D.Valle; McGraw-Hill Inc.</journal><year>1995</year><book /><volume>1</volume><number>0</number><pages>1233-1238</pages><co_aut>Dancis J</co_aut></literature><literature><id>229</id><title>Peroxisomal disorders</title><author>Heymans HS</author><journal>J Inherit Metab Dis</journal><year>1995</year><book /><volume>0</volume><number>0</number><pages>421-433</pages><co_aut>Wanders RJA, Schutgens RBH</co_aut></literature><literature><id>232</id><title>Clinical approach to inherited peroxisomal disorders</title><author>Poggi-Travert F</author><journal>J Inher Met Dis Suppl</journal><year>1995</year><book /><volume>18</volume><number>0</number><pages>1-18</pages><co_aut>et al.</co_aut></literature></Literatures></Disease>